ETON Eton Pharmaceuticals, Inc. stock chart & analysis

Conviction 46HealthcareScan · Fri, Nov 6, 2026

Eton Pharmaceuticals, Inc. (ETON) closed at $56.46 (+19.75%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 99, -15.0% from its 52-week high, +233.8% year to date. Sector: Healthcare · Pharmaceutical Preparations.

ETON$56.46+19.75%

ResistanceSupportVol 14Insider sell

Loading chart…

Why ETON moved

From the StockSetups movers recaps that covered ETON, newest first. A recap states what was known that day.

Nov 5, 2026After hours+23.3%
Eton Pharmaceuticals rose 23.3% after hours to $58.20 on 700,845 shares, against a 20-day average of 403,018. Market cap is about $1.4 billion.
After-Hours Movers Nov 5, 2026: Why CIIT, ETON, FROG Jumped →

Eton Pharmaceuticals, Inc.Pharmaceutical Preparationswww.etonpharma.com ↗

Price56.46

Change+19.75%

Gap+24.26%

Rel volume4.44×

Avg volume489.68K

Avg $ vol25.47M

SMA 2051.34

SMA 5054.80

SMA 20036.61

Price vs 50+2.99%

Price vs 200+54.19%

MA stackbullish

50/200 cross—

Supertrenddown · 57.89

RSI (14)59

MACD hist0.36

MACD crossbull · 0d

Stoch %K / %D81 / 42

ADX (14)24

+DI / −DI23 / 21

RSI divergence—

MACD divergence—

ATR %6.08%

ADR %5.38%

52w high66.37

52w low14.27

From 52w high-14.96%

Above 52w low+295.52%

New 52w highNo

SqueezeOn · 3d

Bollinger width16.37%

%B1.11

Donchian pos81.40%

Donchian high58.59

Donchian low47.03

AVWAP (52w high)55.65

vs AVWAP high+1.41%

AVWAP (52w low)40.61

vs AVWAP low+38.99%

OBV trendFlat

Chaikin MF (20)-0.16

Today vs 20d4.44×

Avg vol (14d)504K

Avg vol (20d)489.68K

Avg $ vol (20d)25.47M

Market cap1.63B

RS Rating99 / 99

RS 3m (vs SPY)+34.11%

RS 6m (vs SPY)+90.66%

RS line new highNo

Trend template8/8

Technical rank92.2

1 week+8.16%

1 month+3.09%

3 months+29.24%

6 months+90.35%

1 year+193.19%

YTD+233.77%

P/E-353.80

P/B18.73

P/S20.36

P/FCF159.73

EPS-0.1700

Div yield—

ROE-5.29%

ROA-2.93%

Debt/Eq0.27

Current1.79

EV/EBITDA498.53

Gross margin53.46%

Net margin-5.75%

Rev growth104.94%

EPS growth-20.35%

Price target80.67

Target upside42.93%

Analyst ratingBuy

Institutional76.13%

Ent. value1.6B

Revenue57.92M

Net income35.25M

Gross profit44.3M

Free cash flow10.19M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out27.39M

Employees44

ListedWed, Nov 14, 2018

Free float24.33M

Float %88.9%

Short interest—

Days to cover—

Short volume44.5%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est$1.06 vs $0.34

Last surprise+211.8% beat

Setup gradeD

Conviction46 / 100

Pattern quality—

Tech rank92.2 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance59.30

Support48.58

Days since event—

Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

ETON technical analysis

Trend

ETON is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 3.0% above the 50-day ($54.80) and 54.2% above the 200-day ($36.61). ADX(14) at 24 points to a moderate trend. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 59, in the bullish half of its range. MACD crossed above its signal line on the latest session. Its RS Rating of 99 puts its weighted 12-month performance ahead of about 99% of the US market.

Volume and volatility

Volume on the latest session ran 4.4× its 20-day average. It trades about $25.5M a day on average. ATR(14) is $3.43, 6.1% of price — its typical daily range. Bollinger Bands are in a squeeze (3 sessions) — volatility is compressed. Chaikin Money Flow (-0.16) shows distribution.

Key levels

The chart pattern's support is $48.58 and its resistance $59.30. The 52-week range is $14.27 to $66.37; price is 15.0% below the high and 295.5% above the low. The VWAP anchored at the 52-week high is $55.65, below price.

Performance

ETON returned +8.2% (1 week), +3.1% (1 month), +29.2% (3 months), +90.3% (6 months), +193.2% (1 year), +233.8% (year to date).

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Pharmaceutical Preparations · Listed 2018 · 44 employees

Insider activity

SEC Form 4 transactions in ETON · open-market 5 sells

Insider	Side	Shares	Value	Traded	Filed
MAIER PAUL V Director · Common Stock · 2026-08-28	Exercise	50K	$189K	2026-08-28	2026-08-31
MAIER PAUL V Director · Common Stock · 2026-08-28	Sell	36.39K	$2.1M	2026-08-28	2026-08-31
MAIER PAUL V Director · Common Stock · 2026-08-28	Sell	13.48K	$812K	2026-08-28	2026-08-31
MAIER PAUL V Director · Common Stock · 2026-08-28	Sell	128	$8K	2026-08-28	2026-08-31
MAIER PAUL V Director · Common Stock · 2026-08-28	Exercise	12.5K	$91K	2026-08-28	2026-08-31
MAIER PAUL V Director · Employee Stock Option · 2026-08-28	Exercise	50K	—	2026-08-28	2026-08-31
MAIER PAUL V Director · Employee Stock Option · 2026-08-28	Exercise	12.5K	—	2026-08-28	2026-08-31
MAIER PAUL V Director · Common Stock · 2026-08-28	Exercise	50K	$189K	2026-08-28	2026-08-28
MAIER PAUL V Director · Common Stock · 2026-08-28	Sell	36.39K	$2.1M	2026-08-28	2026-08-28
MAIER PAUL V Director · Common Stock · 2026-08-28	Sell	13.48K	$812K	2026-08-28	2026-08-28

SEC filings

EDGAR filings in ETON · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.